Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples